EUVIMEDEUVIMED entdecken
Crossref

Immunomorphometric Analysis of CD82 in Colorectal Carcinoma and its Prognostic Significance

Marwa E. Shabana, Ahmed S.A Soliman, Dalia M. Abouelfadl, Noha N. Yassen

Disease and Diagnosis · 2024

DOI: 10.34172/ddj.1564 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Disease and Diagnosis, 2024. Verfasst von Marwa E. Shabana und 3 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Colorectal carcinoma (CRC) is a highly aggressive tumor of the digestive tract, and its incidence and mortality rates are gradually rising. Tumor metastasis is considered a major obstacle to successful treatment. Therefore, assessing new biomarkers of CRC metastasis and prognosis is mandatory. CD82 is regarded as a wide-spectrum metastasis and invasion suppressor. Loss of CD82 expression is a commonly notable biological characteristic of colon carcinoma. This study aimed to evaluate the immunohistochemical expression of KAI-1/CD82 as prognostic markers in various stages of CRC. Materials and Methods: Paraffin blocks and clinicopathological data of 50 patients with CRC were obtained from private laboratories. The expression of CD82 tumor cells was immunohistochemically assessed by image analysis in all specimens of CRC. CD82 cell tumor cell expression was classified into low and high groups.

Results

Among the 50 cases of CRC, 18 (36%) had high levels of positive KAI1/CD82 expression, whereas 32 cases (64%) had low levels. The immunohistochemical expression of KAI1/CD82 in CRC cases under investigation showed statistically significant inverse correlations with depth of invasion, presence of distant metastasis, stage, and Duke’s classification, but not with tumor grade or lymph node metastasis.

Conclusion

Accordingly, immunomorphometric analysis of CD82 in tumor cells can be utilized as an accurate tool to assess factors such as prognosis, treatment response, metastatic disease, and tumor recurrence. KAI1/CD82 may be viable therapeutic targets to reduce the risk of CRC patients developing metastatic disease.

Zitieren

APA

Shabana, M. E., Soliman, A. S., Abouelfadl, D. M., & Yassen, N. N. (2024). Immunomorphometric Analysis of CD82 in Colorectal Carcinoma and its Prognostic Significance. Disease and Diagnosis. https://doi.org/10.34172/ddj.1564

Vancouver

Shabana ME, Soliman AS, Abouelfadl DM, Yassen NN. Immunomorphometric Analysis of CD82 in Colorectal Carcinoma and its Prognostic Significance. Disease and Diagnosis. 2024. doi:10.34172/ddj.1564

BibTeX
@article{Shabana2024,
  author = {Shabana, Marwa E. and Soliman, Ahmed S.A and Abouelfadl, Dalia M. and Yassen, Noha N.},
  title = {Immunomorphometric Analysis of CD82 in Colorectal Carcinoma and its Prognostic Significance},
  journal = {Disease and Diagnosis},
  year = {2024},
  doi = {10.34172/ddj.1564}
}
Kostenlos starten →